BLOG
Cannabis Rescheduling Could Reshape Arizona’s Cannabis Market Federal momentum toward rescheduling cannabis is creating new opportunities for Arizona’s regulated cannabis industry. As outlined by AZ Big Media, moving cannabis from Schedule I to Schedule III under the Controlled Substances Act would formally recognize its medical use and lower risk profile, even though it would not … Continue reading “Cannabis Rescheduling Could Reshape Arizona’s Cannabis Market”
U.S. Cannabis Industry Poised to Surpass $29 Billion in 2025 The U.S. cannabis market is projected to exceed $29 billion in revenue in 2025, according to Whitney Economics. This follows strong 2024 sales, underscoring the sector’s resilience even as it faces evolving market conditions, pricing pressures, and regulatory challenges. Emerging states such as New York, … Continue reading “U.S. Cannabis Industry Poised to Surpass $29 Billion in 2025”
Inside South Carolina’s Medical Marijuana Framework: Licensing Opportunities Under SB 53 South Carolina continues to advance discussions around a regulated medical cannabis program through Senate Bill 53, known as the South Carolina Compassionate Care Act. The proposed legislation would amend the South Carolina Code of Laws to allow the sale of cannabis products for therapeutic … Continue reading “Inside South Carolina’s Medical Marijuana Framework”
Cannabis Enters a New Era: Why Schedule III Makes License Acquisition a Strategic Imperative The signing by President Trump of today’s executive order rescheduling cannabis from Schedule I to Schedule III is undeniably historic. It marks the most consequential federal action on cannabis policy in more than fifty years and represents a formal acknowledgment by … Continue reading “President Trump Reschedules Marijuana: How This Impacts Licensing”
IT’S TIME TO GET GROWING.
Better growth and a clear plan forward is what your business needs. Reach out to us to book a consultation or get your action plan
started.